Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

625
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
625
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

245
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
245
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

756
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
756
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

928
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
928
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

56
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
56
Dementia01:30

Dementia

155
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Analysis of expert diagnostics and identification of sharp objects on putrefactively altered corpses in the Republic of Bashkortostan for 2013-2023].

Sudebno-meditsinskaia ekspertiza·2026
Same author

[Features of forensic medical examination in the study of stab wounds in exhumed corpses (experimental study)].

Sudebno-meditsinskaia ekspertiza·2026
Same author

[On the possibility of establishing postmortem interval of human by examining the electrical conductivity of the knee joints' synovial fluid].

Sudebno-meditsinskaia ekspertiza·2025
Same author

Machine learning-based mapping of Acidobacteriota and Planctomycetota using 16 S rRNA gene metabarcoding data across soils in Russia.

Scientific reports·2025
Same author

Protein Kinase A Inhibitor Attenuates the Antinociceptive Effect of NMDA-Receptor Channel Antagonists in the Capsaicin Test in Mice.

Bulletin of experimental biology and medicine·2024
Same author

[Problems of ethyl glucuronide use in ethanol consumption diagnosis].

Sudebno-meditsinskaia ekspertiza·2024

Related Experiment Video

Updated: Aug 23, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

941

[Testosterone and Alzheimer's disease].

K O Kuznetsov1, R R Khaidarova2, R H Khabibullina3

  • 1N.I. Pirogov Russian national research medical university.

Problemy Endokrinologii
|November 7, 2022
PubMed
Summary
This summary is machine-generated.

Low testosterone levels increase Alzheimer's disease (AD) risk. Testosterone therapy may improve cognitive function and slow AD progression in men and women, especially when started early.

More Related Videos

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.3K
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

15.2K

Related Experiment Videos

Last Updated: Aug 23, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

941
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.3K
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

15.2K

Area of Science:

  • Neuroendocrinology
  • Neurodegenerative diseases

Context:

  • Alzheimer's disease (AD) is a leading cause of dementia, with multifactorial etiopathogenesis.
  • Sex hormones, particularly androgens, play a crucial role in brain function and AD development, with higher incidence in women.
  • Existing research shows clinical inconsistencies regarding the influence of androgens on AD.

Purpose:

  • To evaluate the impact of androgen deprivation therapy (ADT) and testosterone therapy on Alzheimer's disease (AD) risk and progression.
  • To investigate the role of testosterone (T) in maintaining normal brain function and its therapeutic potential in AD.

Summary:

  • Low circulating androgen levels are identified as a significant risk factor for AD and memory loss.
  • Testosterone administration in men with low T levels has shown to improve cognitive performance and memory, particularly when initiated early.
  • Androgens demonstrate a protective effect in both men and women with AD, improving mental state and slowing disease progression.

Impact:

  • Findings suggest androgens are beneficial for AD patients, highlighting low testosterone as a modifiable risk factor.
  • Highlights the potential of testosterone therapy as an early intervention strategy to mitigate AD development and progression.
  • Emphasizes the need for large-scale studies with detailed analysis of personality factors and cognitive assessments to establish causal relationships for testosterone administration in AD.